NDC51407-0262-30: OLANZAPINE TABLETS.
The OLANZAPINE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, primary_container_type: BOTTLE, total_primary_container_quantity: 30, primary_container_content_quantity: 30.0 TABLETS, part_name_assigned_by_controlling_agency: OLANZAPINE TABLETS 10MG BOTTLE OF 30S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-726-6687, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| total_primary_container_quantity | 30 |
| primary_container_content_quantity | 30.0 TABLETS |
| part_name_assigned_by_controlling_agency | OLANZAPINE TABLETS 10MG BOTTLE OF 30S |
| NSN | 6505-01-726-6687 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 30.0 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | OLANZAPINE TABLETS 10MG ORALLY DISINTEGRATING TABLETS (ODT) BOTTLE OF 30S. STORE AT CONTROLLED ROOM TEMPERATURE 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED FROM 15 C TO 30 C (59 F TO 86 F). PROTECT FROM LIGHT AND MOISTURE. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | OLANZAPINE TABLETS 10MG BOTTLE OF 30S |
| TOTAL PRIMARY CONTAINER QUANTITY | 30 |